28232 Federal Register / Vol. 83, No. 117 / Monday, June 18, 2018 / Notices 

disease. The advice provided by the 

Committee will assist in ensuring 

scientific quality, timeliness, utility, and 

dissemination of credible appropriate 

messages and resource materials. 

Matters to be Considered: The agenda 

will include discussions on current and 

emerging topics related to breast cancer 

in young women. These will include 

public health communication, breast 

cancer in young women digital and 

social media campaign, CDC updates, 

and updates from the field. Agenda 

items are subject to change as priorities 

dictate. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–13047 Filed 6–15–18; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–18–17AUZ] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled ‘‘Project NICE: 

Navigating Insurance Coverage 

Expansion’’ to the Office of Management 

and Budget (OMB) for review and 

approval. CDC previously published a 

‘‘Proposed Data Collection Submitted 

for Public Comment and 

Recommendations’’ notice on November 

13, 2017, to obtain comments from the 

public and affected agencies. CDC did 

not receive comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Direct 

written comments and/or suggestions 

regarding the items contained in this 

notice to the Attention: CDC Desk 

Officer, Office of Management and 

Budget, 725 17th Street NW, 

Washington, DC 20503 or by fax to (202) 

395–5806. Provide written comments 

within 30 days of notice publication. 

Proposed Project 

Project NICE: Navigating Insurance 

Coverage Expansion—New—National 

Center for HIV/AIDS, Viral Hepatitis, 

STD, and TB Prevention (NCHHSTP), 

Centers for Disease Control and 

Prevention (CDC). 

Background and Brief Description 

CDC is requesting a three-year 

approval to evaluate the efficacy of an 

in-person health insurance enrollment 

assistance intervention among 1,000 

Black and Hispanic men who have sex 

with men (MSM) and transgender 

persons ages ≥18 years living in the 

Chicago, Illinois metropolitan area. 

In 2013, MSM accounted for 81% of 

new HIV infections among males and 

65% of all new HIV infections. In 2010 

African Americans comprised only 12% 

of the US population, but Black MSM 

nearly equaled White MSM in numbers 

of new HIV infections (10,600 and 

11,200, respectively). In 2010 Hispanics 

comprised 17% of the US population, 

and Hispanic MSM accounted for 22% 

(6,700) of all new HIV infections. A 

2008 systematic review found HIV rates 

among Black and Hispanic transgender 

women to be 56% and 16%, 

respectively. Contributing to these 

disproportionate HIV rates are that 

Black and Hispanic MSM and 

transgender persons face obstacles in 

seeking medical care and following 

through with referrals or appointments, 

including lack of health insurance. 

The intervention being evaluated in 

this study (in-person health insurance 

enrollment assistance) is not a new 

activity. This study will evaluate 

whether moving the delivery of inperson health insurance enrollment 

assistance, from the first clinic visit after 

receipt of an HIV test result, to earlier 

in the care continuum during the HIV 

testing event, will impact health 

outcomes. Because this study does not 

introduce new intervention activities, 

only reorders the sequence of delivery 

of standard practice, the burden to the 

participant experience will be data 

collection forms and research 

procedures only. 

The goal of this study is to test 

whether providing a point of care, inperson assistance in enrolling in private 

health insurance or Medicaid for the 

first time, changing to a different 

insurance plan, or understanding how 

to use current insurance policies 

following HIV testing will (1) increase 

the proportion of participants who 

obtain health insurance; (2) result in 

better health outcomes among 

participants (e.g., achieving viral 

suppression, remaining HIV negative); 

(3) improve the linkage and retention 

rates for HIV care (i.e., HIV treatment, 

Pre-exposure Prophylaxis (PrEP)) and 

other HIV-associated health services 

(e.g., mental health counseling, 

substance use treatment) of participants, 

especially those diagnosed with HIV; 

and (4) increase HIV care linkage and 

retention rates sufficiently to justify the 

cost of implementing the intervention 

(cost-benefit analysis) among Black and 

Hispanic MSM and transgender persons 

age 18 or older in the Chicago, Illinois 

metropolitan area. 

This study is funded through a 

cooperative agreement between CDC 

and the University of Chicago Medicine. 

Three partner agencies will conduct the 

intervention: (1) University of Chicago 

Medicine (the lead partner agency), (2) 

Howard Brown Health, and (3) Chicago 

House and Social Service Agency 

(Chicago House). These three partner 

agencies currently provide in-person 

health insurance enrollment assistance, 

linkage to care (HIV-related treatment, 

primary care), and patient navigation 

services to the study population. 

This study uses a randomized 

controlled trial design, which will 

enhance scientific validity and the 

policy impact of the intervention, and 

help researchers assess the efficacy of 

this intervention as an emerging 


amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 83, No. 117 / Monday, June 18, 2018 / Notices 28233 

practice. This study aligns with 

National HIV/AIDS Strategy 2020 and 

Healthy People 2020 objectives of 

reducing new HIV infections, increasing 

access to care and improving health 

outcomes for people living with HIV, 

and reducing HIV-related health 

disparities. This study also aligns with 

the Office of Management and Budget’s 

emphasis on application of behavioral 

insights in that it restructures the 

context (i.e., after HIV testing) in which 

health-related decision-making (i.e., 

health insurance enrollment) occurs in 

order to promote the selection of 

beneficial options (i.e., attending HIVrelated medical care appointments). 

This proposed health insurance 

enrollment assistance study has the 

potential for widespread health 

improvements for Black and Hispanic 

MSM and transgender persons 

regardless of their HIV status. 

At this time, CDC is not partnering 

with other HHS agencies for this study. 

However, we have discussed the study 

with HRSA/HAB and HHS/OD, and 

plan to apprise CMS and HRSA of the 

project before implementation and 

invite CMS and HRSA representatives to 

serve as consultants. HHS may also 

direct us to the CMS regional officer for 

Chicago, Illinois. Additionally, there is 

the potential to have CMS grantee 

navigators supplement partner agency 

navigators during outreach HIV testing 

events. For this study, CDC is not 

engaged in research, and therefore not 

involved in data collection activities. 

The grantee is responsible for 

implementing the intervention and 

collecting data from the proposed 1,000 

participants. Thus, CDC will not need 

an interagency data-sharing agreement if 

we do consult with HRSA or CMS. 

The study will enroll 1,000 

participants over 12 months to reach 

adequate power calculations (500 into 

the intervention arm, and 500 into the 

control arm). Approximately 1,500 

individuals will need to be screened to 

identify and enroll 1,000 eligible study 

participants. After an HIV testing 

session at an outreach event or clinic 

visit, partner agency staff will invite 

individuals to participate in the study. 

If individuals are interested, staff will 

screen individuals for eligibility using 

the Participant Eligibility Form 

(Attachment 5) which will take 

approximately 5 minutes to complete. If 

they are determined eligible to 

participate, and still interested in 

participating, the individual will 

complete an Informed Consent Form 

(Attachment 6), which will take 

approximately 10 minutes to complete, 

and the Participant Enrollment Form 

(Attachment 7), which will take 

approximately 35 minutes to complete. 

The total estimated annualized hourly 

burden anticipated for this study is 875 

hours. There is no cost to respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

per response 

(in hours) 

Study participant ............................................. Participant Eligibility Form (Att 5) .................. 1,500 1 5/60 

Study participant ............................................. Informed Consent Form (Att 6) ...................... 1,000 1 10/60 

Study participant ............................................. Participant Enrollment Form (Att 7) ............... 1,000 1 35/60 

Jeffrey M. Zirger, 

Acting Chief, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of the Associate Director for Science, Office 

of the Director, Centers for Disease Control 

and Prevention. 

[FR Doc. 2018–12971 Filed 6–15–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–18–0530] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In accordance with the Paperwork 

Reduction Act of 1995, the Centers for 

Disease Control and Prevention (CDC) 

has submitted the information 

collection request titled Energy 

Employees Occupational Illness 

Compensation Program Act of 2000 

(EEOICPA) Dose Reconstruction 

Interviews and Forms to the Office of 

Management and Budget (OMB) for 

review and approval. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on February 

20, 2018 to obtain comments from the 

public and affected agencies. CDC did 

not receive comments related to the 

previous notice. This notice serves to 

allow an additional 30 days for public 

and affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Direct 

written comments and/or suggestions 

regarding the items contained in this 

notice to the Attention: CDC Desk 

Officer, Office of Management and 

Budget, 725 17th Street NW, 

Washington, DC 20503 or by fax to (202) 

395–5806. Provide written comments 

within 30 days of notice publication. 

Proposed Project 

EEOICPA Dose Reconstruction 

Interviews and Forms, OMB No. 0920– 

0530, expires 04/30/2018— 

Reinstatement without change— 

National Institute for Occupational 

Safety and Health (NIOSH), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

On October 30, 2000, the Energy 

Employees Occupational Illness 


amozie on DSK3GDR082PROD with NOTICES1